Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02322840 · ClinicalTrials.gov registry record · NA
Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System
A NA study of Mitral Valve Insufficiency, sponsored by Medtronic Cardiovascular.
- Active
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 20
- Study locations
NCT02322840 is a NA study of Mitral Valve Insufficiency that is active but no longer recruiting, run by Medtronic Cardiovascular. The registered enrollment target is 128 participants, below the 375-participant average among 11 other Mitral Valve Insufficiency trials with a reported enrollment target (66% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT02322840, a NA study of Mitral Valve Insufficiency, is active but no longer recruiting, sponsored by Medtronic Cardiovascular.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 20
- Study locations
Study Summary
PILOT: The study is a pilot trial to evaluate the safety and performance of the Twelve TMVR System in high risk mitral regurgitation patients. EFS: The study is an Early Feasibility Study to evaluate the safety and performance of the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal access in Patients with moderate-Severe or severe, Symptomatic Mitral Regurgitation
Conditions Studied
Interventions
- DEVICE Twelve TMVR Implant
- DEVICE Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System
Study Locations (20)
New York
- NYU Langone Medical Center - PILOT - New York
- The Mount Sinai Hospital (New York NY) - EFS - New York
- The Mount Sinai Hospital (New York NY) - PILOT - New York
- New York-Presbyterian Hospital Columbia University Medical Center - EFS - New York
- New York-Presbyterian Hospital Columbia University Medical Center - PILOT - New York
Michigan
- University of Michigan Health System - University Hospital - PILOT - Ann Arbor
- Corewell Health - EFS - Grand Rapids
Minnesota
- Abbott Northwestern Hospital - EFS - Minneapolis
- Abbott Northwestern Hospital - PILOT - Minneapolis
Texas
- Baylor Jack and Jane Hamilton Heart and Vascular Hospital - PILOT - Dallas
- Houston Methodist Hospital - PILOT - Houston
Arizona
- Abrazo Arizona Heart Hospital - EFS - Phoenix
California
- Cedars-Sinai Medical Center - PILOT - Los Angeles
Georgia
- Piedmont Atlanta Hospital - PILOT - Atlanta
Illinois
- Northwestern Memorial Hospital - PILOT - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2015-04 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02322840
The ClinicalTrials.gov registry entry for NCT02322840 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 375-participant average among 11 other Mitral Valve Insufficiency trials with a reported enrollment target (66% lower). The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mitral Valve Insufficiency appearing as the primary indexed condition, and to 2 interventions - of which Twelve TMVR Implant is the first listed.
NCT02322840 reports 20 study locations spanning 13 distinct geographic areas - top geographies include New York, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02322840 about?
NCT02322840 is a clinical study titled "Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System". PILOT: The study is a pilot trial to evaluate the safety and performance of the Twelve TMVR System in high risk mitral regurgitation patients. EFS: The study is an Early Feasibility Study to evaluate the safety and performance of the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement Syst...
What is the current status of trial NCT02322840?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2015-04. Estimated completion is 2028-12.
What conditions does trial NCT02322840 study?
This clinical trial studies the following conditions: Mitral Valve Insufficiency.
What interventions are being tested in trial NCT02322840?
The interventions under investigation include: Twelve TMVR Implant (DEVICE), Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System (DEVICE).
Who is sponsoring clinical trial NCT02322840?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02322840 being conducted?
This trial has 20 study locations across Arizona, California, Georgia, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
RECRUITING · NA
-
The ENCIRCLE Trial
RECRUITING · NA
-
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.